MARKET

ORTX

ORTX

Orchard Therapeutics plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.94
+0.44
+3.03%
Closed 16:00 09/20 EDT
OPEN
14.57
PREV CLOSE
14.50
HIGH
15.12
LOW
14.46
VOLUME
159.63K
TURNOVER
--
52 WEEK HIGH
21.64
52 WEEK LOW
8.65
MARKET CAP
1.24B
P/E (TTM)
-9.9329
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ORTX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ORTX News

  • Benzinga's Top Upgrades, Downgrades For September 17, 2019
  • Benzinga.5d ago
  • Guggenheim sees two-bagger in Orchard Therapeutics in premarket analyst action
  • Seeking Alpha - Article.5d ago
  • Guggenheim Initiates Coverage On Orchard Therapeutics with Buy Rating, Announces $31 Price Target
  • Benzinga.5d ago
  • Orchard Therapeutics commercial chief bids adieu
  • seekingalpha.09/13 16:33

More

Industry

Pharmaceuticals
+1.04%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About ORTX

Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.
More

Webull offers Orchard Therapeutics PLC - ADR (ORTX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.